Reasons for Ineligibility in phase 1 and 2A HIV Vaccine Initiative (KAVI), Kenya

dc.contributor.author	Omosa-Manyonyi, Gloria S.
dc.contributor.author	Omu Anzala, Walter Jaoko
dc.contributor.author	Ogutu, Hilda
dc.contributor.author	Wakasiaka, Sabina
dc.contributor.author	Malogo, Roselyn
dc.contributor.author	Nyange, Jacqueline
dc.contributor.author	Njuguna, Pamela
dc.contributor.author	Ndinya-Achola, JO
dc.contributor.author	Bhatt, Kirana
dc.contributor.author	Bashir, Farah
dc.contributor.author	Oyaro, Micah
dc.contributor.author	Schmidt, Claudia
dc.contributor.author	Priddy, Frances
dc.contributor.author	Fast, Patricia
dc.date.accessioned	2013-02-21T08:20:46Z
dc.date.issued	2011
dc.identifier.citation	PLoS ONE	en
dc.identifier.uri	http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/10567
dc.description.abstract	With the persistent challenges towards controlling the HIV epidemic, there is an ongoing need for research into HIV vaccines and drugs. Sub-Saharan African countries - worst affected by the HIV pandemic - have participated in the conduct of clinical trials for HIV vaccines. In Kenya, the Kenya AIDS Vaccine Initiative (KAVI) at the University of Nairobi has conducted HIV vaccine clinical trials since 2001	en
dc.language.iso	en	en
dc.relation.ispartofseries	Volume 6 Issue 1;
dc.subject	Aids Vaccine Initiative	en
dc.title	Reasons for Ineligibility in phase 1 and 2A HIV Vaccine Initiative (KAVI), Kenya	en
dc.type	Article	en
local.embargo.terms	6 months	en
local.embargo.lift	2013-08-20T08:20:46Z
local.publisher	School of nursing science, University of Nairobi	en